effectiveness of oral semaglutide A Review Available Evidence: A New Era of Management of Diabetes with Peptide in a Pill Form Oral Semaglutide, the First Ingestible
Description
No, we do not currently have human clinical trials showing GLP one
We treat a wide range of conditions, including autoimmune diseases, chronic fatigue, mold illness, digestive issues, hormone imbalances, neurological disorders, and pediatric conditions like PANS/PANDAS
There are no major contraindications, but since both medicines lower blood pressure, their combined effect can increase the risk of a noticeable drop in blood pressure
01127-3/asset/9a53cc8c-5dc8-4aac-be86-cece924753b9/main.assets/gr1_lrg.jpg)
That said, many people notice appetite changes within the first one to two weeks
It fits well into a long-term routine, especially for people using GLP-1 medications
